Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA)

CUSIP: 50127T109

Q1 2020 13F Holders as of 31 Mar 2020

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
87,054,674
Total 13F shares
39,802,987
Share change
+814,915
Total reported value
$394,470,751
Price per share
$9.95
Number of holders
113
Value change
+$5,045,270
Number of buys
55
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q1 2020

As of 31 Mar 2020, Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 39,802,987 shares. The largest 10 holders included FMR LLC, EcoR1 Capital, LLC, BlackRock Inc., VICTORY CAPITAL MANAGEMENT INC, BVF INC/IL, VANGUARD GROUP INC, EAGLE ASSET MANAGEMENT INC, CARILLON TOWER ADVISERS, INC., Prosight Management, LP, and STATE STREET CORP. This page lists 113 institutional shareholders reporting positions in this security for the Q1 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.